ResearcherXijing HospitalNo recent work listed

Yong Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3568-6850; OpenAlex author ID A5100454462. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper

Papers 1

Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p. Last author DOI 10.1016/j.canlet.2020.02.033 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dinghuang Zhu · 1 shared paper, 2020 · strength 0.10
- Paper Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p. DOI 10.1016/j.canlet.2020.02.033 ↗
Ning Xie · 1 shared paper, 2020 · strength 0.10
- Paper Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p. DOI 10.1016/j.canlet.2020.02.033 ↗
Xin Guo · 1 shared paper, 2020 · strength 0.10
- Paper Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p. DOI 10.1016/j.canlet.2020.02.033 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.